Back to Companies
Prime Medicine, Inc.
PRMENasdaqCIK: 0001894562
Over the 25 most recent insider filings, Prime Medicine, Inc. (PRME) has seen activity from 13 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $30.0M bought versus $0 sold, a net purchase of $30.0M. Reine Allan (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $10.0M by ARCH Venture Partners X, LLC. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$73.5M
Purchases
$30.0M
Sales
$0
Unique Insiders
13
Recent Insider Trades
25 loaded
| Jun 8 | PRME Prime Medicine, Inc. | Marrazzo Jeffrey D | Director | Award | $229.5K |
| Jun 8 | PRME Prime Medicine, Inc. | Cahill Thomas | Director | Award | $229.5K |
| Jun 8 | PRME Prime Medicine, Inc. | Foster-Cheek Kaye I | Director | Award | $229.5K |
| Jun 8 | PRME Prime Medicine, Inc. | Chung Wendy | Director | Award | $229.5K |
| Jun 8 | PRME Prime Medicine, Inc. | Schenkein David P | Director | Award | $229.5K |
| Jun 8 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Award | $229.5K |
| Jun 8 | PRME Prime Medicine, Inc. | NELSEN ROBERT | Director, 10% Owner | Award | $229.5K |
| Apr 17 | PRME Prime Medicine, Inc. | Makhni Svetlana Ni | Chief Financial Officer | Award | $2.9M |
| Apr 17 | PRME Prime Medicine, Inc. | Makhni Svetlana Ni | Chief Financial Officer | Other | $0 |
| Feb 27 | PRME Prime Medicine, Inc. | Reine Allan | Chief Executive Officer, Director | Award | $5.7M |
| Feb 24 | PRME Prime Medicine, Inc. | Alenson Carman | See Remarks | Award | $467.6K |
| Feb 24 | PRME Prime Medicine, Inc. | LEE ANN L. | Chief Technical Officer | Award | $1.3M |
| Aug 1 | PRME Prime Medicine, Inc. | ARCH Venture Partners X, LLC | 10% Owner | Buy | $10.0M |
| Aug 5 | PRME Prime Medicine, Inc. | Reine Allan | Chief Executive Officer, Director | Award | $9.2M |
| Aug 5 | PRME Prime Medicine, Inc. | Kelly Michael Aaron | Director | Award | $1.7M |
| Aug 5 | PRME Prime Medicine, Inc. | Marrazzo Jeffrey D | Director | Award | $5.4M |
| Aug 5 | PRME Prime Medicine, Inc. | Alenson Carman | See Remarks | Award | $3.0M |
| Aug 1 | PRME Prime Medicine, Inc. | NELSEN ROBERT | Director, 10% Owner | Buy | $10.0M |
| Aug 5 | PRME Prime Medicine, Inc. | Schenkein David P | Director | Award | $1.3M |
| Aug 5 | PRME Prime Medicine, Inc. | Chung Wendy | Director | Award | $1.7M |
| Aug 5 | PRME Prime Medicine, Inc. | Foster-Cheek Kaye I | Director | Award | $1.7M |
| Aug 5 | PRME Prime Medicine, Inc. | LEE ANN L. | Chief Technical Officer | Award | $5.2M |
| Aug 5 | PRME Prime Medicine, Inc. | NELSEN ROBERT | Director, 10% Owner | Award | $1.3M |
| Aug 5 | PRME Prime Medicine, Inc. | Cahill Thomas | Director | Award | $1.3M |
| Aug 1 | PRME Prime Medicine, Inc. | ARCH Venture Partners XII, LLC | 10% Owner | Buy | $10.0M |
25 filings